hers vs noom for glp 1 Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP-1 Crisis Unboxing Noom GLP-1ᴿˣ | My

Unveiling the Therapeutic Potential of the Second-Generation Incretin Analogs Semaglutide and Tirzepatide in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults

GLP-1RA use is associated with health benefits, including weight loss and reduced MACE risk

This isnt to say that they are without any potential drawbacks, such as risk of weight regain when discontinuing the drugs, high price tags impacting accessibility, and, of course, a range of potential adverse physiological side effects

A., Baggio, L

Liraglutide (Saxenda/Victoza, Novo Nordisk) was the most common GLP-1 in the review and was included as the lone therapy in 16 studies and in combination with dulaglutide (Trulicity, Eli Lilly) in two studies

Looking forward, several new GLP-1 medicines are being developed and will likely be released in combination with another medicine, Drucker said